Aghil Sharifzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Aghil Sharifzadeh has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Ali Reza Khosravi
Department of Immunology and Microbiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
12 shared publications Hojjatollah Shokri
Department of Pathobiology, Faculty of Veterinary Medicine, Amol University of Special Modern Technologies, Amol, Iran
7 shared publicationsH. Shokri
Department of Pathobiology, Faculty of Veterinary Medicine, Amol University of Special Modern Technologies, Amol, Iran
5 shared publications- Hojjatollah Shokri
Amol University of Special Modern Technologies
4 shared publications Ali Reza Khosravi
Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
3 shared publications- Bahar Nayeri Fasaei
Department of Microbiology and Immunology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
3 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Nanoformulated silymarin enhances antifungal activity against resistant Candida albicans by reducing ergosterol and binding to cell envelope targets
- 2 October 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessNanoformulated silymarin enhances antifungal activity against resistant Candida albicans by reducing ergosterol and binding to cell envelope targets
- 17 September 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16 (10) , 629
Antifungal Activity and Binding Potential of Nanoencapsulated Propolis Against Key Cell Wall and Plasma Membrane Biosynthetic Enzymes in Resistant Candida albicans
- 17 September 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16 (10) , 629
Antifungal Activity and Binding Potential of Nanoencapsulated Propolis Against Key Cell Wall and Plasma Membrane Biosynthetic Enzymes in Resistant Candida albicans
- Open Access
- 29 August 2026
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (5) , e71205
A Rare Case of Cutaneous Infection by Corynascus verrucosus in a Shih Tzu Dog: Molecular Identification and Phylogenetic Analysis
Background: Fungal infections are important causes of dermatological disease in companion animals and may involve a diverse range of clinically relevant fungal pathogens. Accurate identification of the causative agent is essential for appropriate diagnosis, treatment and assessment of potential zoonotic risks. Objectives: This study aimed to characterize a fungal isolate from a canine cutaneous lesion in Tehran, Iran, using morphological, molecular and phylogenetic analyses. Methods: Skin scrapings were aseptically collected from a dog presenting with pruritus and scaling, using sterile techniques microscopic examination and fungal culture. Microbiological observations were inconclusive for species‐level identification. Hence, target isolate was subjected to PCR amplification of the internal transcribed spacer (ITS) region using ITS1 and ITS4 universal primers. Results: The ITS1–5.8S rDNA–ITS2 region was successfully amplified and sequenced using the universal ITS1 and ITS4 primers, and the sequence was deposited in the NCBI GenBank (PV082530). BLAST analysis showed 99.36% nucleotide similarity to a reference sequence of Corynascus verrucosus . In the maximum likelihood analysis placed the Iranian isolate within the broader Corynascus lineage, clustering closely with C. verrucosus reference sequences from different geographic regions. Morphological findings, particularly large, round, verrucose conidia, supported the molecular identification. Overall, the combined morphological, molecular and phylogenetic findings supported identification as C. verrucosus . Conclusions: This case highlights the occurrence of an uncommon C. verrucosus isolate in a canine cutaneous lesion and demonstrates the value of integrating morphological, molecular, and phylogenetic approaches for fungal identification. The findings also emphasize the importance of cautious interpretation of molecular data when closely related fungal taxa show high sequence similarity.
- 29 August 2026
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (5) , e71205
Open AccessA Rare Case of Cutaneous Infection by Corynascus verrucosus in a Shih Tzu Dog: Molecular Identification and Phylogenetic Analysis
Background: Fungal infections are important causes of dermatological disease in companion animals and may involve a diverse range of clinically relevant fungal pathogens. Accurate identification of the causative agent is essential for appropriate diagnosis, treatment and assessment of potential zoonotic risks. Objectives: This study aimed to characterize a fungal isolate from a canine cutaneous lesion in Tehran, Iran, using morphological, molecular and phylogenetic analyses. Methods: Skin scrapings were aseptically collected from a dog presenting with pruritus and scaling, using sterile techniques microscopic examination and fungal culture. Microbiological observations were inconclusive for species‐level identification. Hence, target isolate was subjected to PCR amplification of the internal transcribed spacer (ITS) region using ITS1 and ITS4 universal primers. Results: The ITS1–5.8S rDNA–ITS2 region was successfully amplified and sequenced using the universal ITS1 and ITS4 primers, and the sequence was deposited in the NCBI GenBank (PV082530). BLAST analysis showed 99.36% nucleotide similarity to a reference sequence of Corynascus verrucosus . In the maximum likelihood analysis placed the Iranian isolate within the broader Corynascus lineage, clustering closely with C. verrucosus reference sequences from different geographic regions. Morphological findings, particularly large, round, verrucose conidia, supported the molecular identification. Overall, the combined morphological, molecular and phylogenetic findings supported identification as C. verrucosus . Conclusions: This case highlights the occurrence of an uncommon C. verrucosus isolate in a canine cutaneous lesion and demonstrates the value of integrating morphological, molecular, and phylogenetic approaches for fungal identification. The findings also emphasize the importance of cautious interpretation of molecular data when closely related fungal taxa show high sequence similarity.
- Open Access
- 23 May 2025
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (3) , e70407
Evaluating the Antimicrobial and Antibiofilm Efficacy of Lavender Essential Oil and Linalool on Dual Candida albicans Biofilms With Staphylococcus aureus and Staphylococcus epidermidis From Canine External Otitis
Background: Biofilm formation significantly contributes to the rise of antimicrobial resistance, treatment failures and recurrent infections. Essential oils (EOs), particularly lavender EO (LEO), have gained attention for their antimicrobial and antibiofilm activities. This study investigates the effects of LEO and linalool on Staphylococcus aureus ( S. aureus ), Staphylococcus epidermidis ( S. epidermidis ), and Candida albicans ( C. albicans ) isolates. Materials and Methods: The chemical composition of LEO was analysed using gas chromatography‐mass spectrometry (GC‐MS). Eight clinical and reference microorganisms were tested, including four C. albicans , three S. aureus , and three S. epidermidis isolates, to assess their biofilm‐producing potential with the tissue microtiter plate method. Antimicrobial and antibiofilm activities of LEO and linalool were evaluated in planktonic, single‐biofilm, and dual‐biofilm phases through microbroth dilution and scanning electron microscopy (SEM). Results: The minimum inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration (MBC/MFC) of LEO in the planktonic phase were 1250 µg/mL and 2500 µg/mL against Staphylococcus isolates, respectively, while the corresponding value for C. albicans isolates was 5000 µg/mL. 90% biofilm inhibition was achieved at concentrations of 5000 µg/mL and 40,000 µg/mL for Staphylococcus and C. albicans , respectively. LEO completely inhibited dual biofilms formed by C. albicans / S. aureus and C. albicans / S. epidermidis at 20,000 µg/mL, whereas linalool attained 100% inhibition at 40,000 µg/mL. Conclusion: LEO demonstrates significant antimicrobial and antibiofilm activity against Staphylococcus and C. albicans isolates, effective in both planktonic and biofilm phases.
- 23 May 2025
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (3) , e70407
Open AccessEvaluating the Antimicrobial and Antibiofilm Efficacy of Lavender Essential Oil and Linalool on Dual Candida albicans Biofilms With Staphylococcus aureus and Staphylococcus epidermidis From Canine External Otitis
Background: Biofilm formation significantly contributes to the rise of antimicrobial resistance, treatment failures and recurrent infections. Essential oils (EOs), particularly lavender EO (LEO), have gained attention for their antimicrobial and antibiofilm activities. This study investigates the effects of LEO and linalool on Staphylococcus aureus ( S. aureus ), Staphylococcus epidermidis ( S. epidermidis ), and Candida albicans ( C. albicans ) isolates. Materials and Methods: The chemical composition of LEO was analysed using gas chromatography‐mass spectrometry (GC‐MS). Eight clinical and reference microorganisms were tested, including four C. albicans , three S. aureus , and three S. epidermidis isolates, to assess their biofilm‐producing potential with the tissue microtiter plate method. Antimicrobial and antibiofilm activities of LEO and linalool were evaluated in planktonic, single‐biofilm, and dual‐biofilm phases through microbroth dilution and scanning electron microscopy (SEM). Results: The minimum inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration (MBC/MFC) of LEO in the planktonic phase were 1250 µg/mL and 2500 µg/mL against Staphylococcus isolates, respectively, while the corresponding value for C. albicans isolates was 5000 µg/mL. 90% biofilm inhibition was achieved at concentrations of 5000 µg/mL and 40,000 µg/mL for Staphylococcus and C. albicans , respectively. LEO completely inhibited dual biofilms formed by C. albicans / S. aureus and C. albicans / S. epidermidis at 20,000 µg/mL, whereas linalool attained 100% inhibition at 40,000 µg/mL. Conclusion: LEO demonstrates significant antimicrobial and antibiofilm activity against Staphylococcus and C. albicans isolates, effective in both planktonic and biofilm phases.
- Open Access
- 5 May 2025
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (3) , e70352
Synergistic Antifungal Efficacy of Eugenol‐Loaded Nanocapsules Combined With Itraconazole Against Trichophyton mentagrophytes
Background and Objectives: The increasing prevalence of dermatophyte infections and the emergence of antifungal resistance highlight the urgent need for novel treatment approaches. Trichophyton mentagrophytes , a common dermatophyte, often resists standard antifungal therapies, necessitating alternative solutions. Eugenol, a natural compound with potent antifungal properties, has gained attention for its synergistic effects with conventional antifungal agents. However, its clinical application is limited by poor bioavailability and stability. Nanoencapsulation of eugenol offers a promising strategy to enhance its antifungal efficacy and address these limitations. This study aims to evaluate the antifungal efficacy of eugenol and nanoencapsulated eugenol in combination with Itraconazole against T. mentagrophytes isolates. Methods: Eugenol‐loaded nanocapsules were fabricated using the nanoprecipitation method and subsequently evaluated. The antifungal activity of eugenol, nano‐eugenol and Itraconazole—individually and in combination—was assessed against clinical isolates of T. mentagrophytes derived from animal and human sources, using minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) determinations. The chequerboard assay evaluated the synergistic effects. Results: Scanning electron microscopy (SEM) and dynamic light scattering (DLS) analyses showed that eugenol nanocapsules have a uniform, spherical morphology with an average size of 150.9 nm and moderate polydispersity (polydispersity index [PDI] = 0.531), whereas a slight negative zeta potential (−0.1 mV) contributes to suspension stability by minimizing aggregation. The geometric mean MIC of eugenol was 119.3 µg/mL, significantly lower than that of nano‐eugenol (477.4 µg/mL), whereas Itraconazole had the lowest MIC at 11 µg/mL. Eugenol demonstrated a more potent fungicidal effect than its nanoencapsulated form, though nanoencapsulation improved stability and bioavailability. Combining Itraconazole with nano‐eugenol showed synergy in 73.3% of T. mentagrophytes isolates, reducing Itraconazole's MIC by up to 1/2 or 1/4. Both forms of eugenol exhibited effective anti‐dermatophytic activity. Conclusion: The findings suggest that nanoencapsulated eugenol, in combination with Itraconazole, provides a potent and synergistic antifungal approach against T. mentagrophytes , potentially reducing the dosage and resistance risks associated with Itraconazole. These results underscore the potential of nano‐enhanced plant extracts in developing effective, sustainable antifungal therapies.
- 5 May 2025
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (3) , e70352
Open AccessSynergistic Antifungal Efficacy of Eugenol‐Loaded Nanocapsules Combined With Itraconazole Against Trichophyton mentagrophytes
Background and Objectives: The increasing prevalence of dermatophyte infections and the emergence of antifungal resistance highlight the urgent need for novel treatment approaches. Trichophyton mentagrophytes , a common dermatophyte, often resists standard antifungal therapies, necessitating alternative solutions. Eugenol, a natural compound with potent antifungal properties, has gained attention for its synergistic effects with conventional antifungal agents. However, its clinical application is limited by poor bioavailability and stability. Nanoencapsulation of eugenol offers a promising strategy to enhance its antifungal efficacy and address these limitations. This study aims to evaluate the antifungal efficacy of eugenol and nanoencapsulated eugenol in combination with Itraconazole against T. mentagrophytes isolates. Methods: Eugenol‐loaded nanocapsules were fabricated using the nanoprecipitation method and subsequently evaluated. The antifungal activity of eugenol, nano‐eugenol and Itraconazole—individually and in combination—was assessed against clinical isolates of T. mentagrophytes derived from animal and human sources, using minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) determinations. The chequerboard assay evaluated the synergistic effects. Results: Scanning electron microscopy (SEM) and dynamic light scattering (DLS) analyses showed that eugenol nanocapsules have a uniform, spherical morphology with an average size of 150.9 nm and moderate polydispersity (polydispersity index [PDI] = 0.531), whereas a slight negative zeta potential (−0.1 mV) contributes to suspension stability by minimizing aggregation. The geometric mean MIC of eugenol was 119.3 µg/mL, significantly lower than that of nano‐eugenol (477.4 µg/mL), whereas Itraconazole had the lowest MIC at 11 µg/mL. Eugenol demonstrated a more potent fungicidal effect than its nanoencapsulated form, though nanoencapsulation improved stability and bioavailability. Combining Itraconazole with nano‐eugenol showed synergy in 73.3% of T. mentagrophytes isolates, reducing Itraconazole's MIC by up to 1/2 or 1/4. Both forms of eugenol exhibited effective anti‐dermatophytic activity. Conclusion: The findings suggest that nanoencapsulated eugenol, in combination with Itraconazole, provides a potent and synergistic antifungal approach against T. mentagrophytes , potentially reducing the dosage and resistance risks associated with Itraconazole. These results underscore the potential of nano‐enhanced plant extracts in developing effective, sustainable antifungal therapies.
- Open Access
- 12 April 2025
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 17 (2) , 312-320
Impact of oleuropein on Candida albicans and Staphylococcus aureus adhesion and its mediated toxicity in Zebrafish (Danio rerio) embryos
Background and Objectives: The rising prevalence of antibiotic resistance and biofilm-associated infections poses signif- icant challenges in clinical settings. This study investigates the antimicrobial and anti-adhesive properties of oleuropein, a compound derived from olive leaves, against Candida albicans and Staphylococcus aureus. Materials and Methods: This study was conducted on Candida albicans (fluconazole-resistant/susceptible) and Staphylo- coccus aureus (methicillin-resistant/susceptible). The antifungal, antibacterial, anti-adhesion, and cell surface hydrophobic- ity (CSH) effects of oleuropein were evaluated. The impact of oleuropein on germ tube formation (GTF) in C. albicans was assessed. Finally, the toxicity of oleuropein was evaluated in zebrafish embryos. Results: Oleuropein exhibited MIC values of 10 mg/ml for C. albicans and 5 mg/ml for S. aureus. It significantly (P< 0.05) reduced the adhesion of both microorganisms in a dose-dependent manner, with inhibition percentages of 78.43% and 75.91% for C. albicans and S. aureus, respectively. Additionally, oleuropein reduced the CSH of C. albicans, indicating its potential to interfere with adhesion mechanisms. In addition, oleuropein exhibited inhibition of GTF in C. albicans. Conclusion: Oleuropein demonstrates significant antimicrobial and anti-adhesive properties against C. albicans and S. au- reus, indicating its potential as a therapeutic agent for preventing biofilm-related infections. However, careful dosage man- agement is crucial due to its observed toxicity at higher concentrations.
- 12 April 2025
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 17 (2) , 312-320
Open AccessImpact of oleuropein on Candida albicans and Staphylococcus aureus adhesion and its mediated toxicity in Zebrafish (Danio rerio) embryos
Background and Objectives: The rising prevalence of antibiotic resistance and biofilm-associated infections poses signif- icant challenges in clinical settings. This study investigates the antimicrobial and anti-adhesive properties of oleuropein, a compound derived from olive leaves, against Candida albicans and Staphylococcus aureus. Materials and Methods: This study was conducted on Candida albicans (fluconazole-resistant/susceptible) and Staphylo- coccus aureus (methicillin-resistant/susceptible). The antifungal, antibacterial, anti-adhesion, and cell surface hydrophobic- ity (CSH) effects of oleuropein were evaluated. The impact of oleuropein on germ tube formation (GTF) in C. albicans was assessed. Finally, the toxicity of oleuropein was evaluated in zebrafish embryos. Results: Oleuropein exhibited MIC values of 10 mg/ml for C. albicans and 5 mg/ml for S. aureus. It significantly (P< 0.05) reduced the adhesion of both microorganisms in a dose-dependent manner, with inhibition percentages of 78.43% and 75.91% for C. albicans and S. aureus, respectively. Additionally, oleuropein reduced the CSH of C. albicans, indicating its potential to interfere with adhesion mechanisms. In addition, oleuropein exhibited inhibition of GTF in C. albicans. Conclusion: Oleuropein demonstrates significant antimicrobial and anti-adhesive properties against C. albicans and S. au- reus, indicating its potential as a therapeutic agent for preventing biofilm-related infections. However, careful dosage man- agement is crucial due to its observed toxicity at higher concentrations.
- Open Access
- 10 September 2024
- Published by Springer Nature in BMC Microbiology
- Vol. 24 (1) , 1-12
Evaluation of antifungal and apoptotic effects of linalool, citral, and carvacrol separately and in combination with nystatin against clinical isolates of Pichia kudriavzevii
Pichia kudriavzevii (formerly Candida krusei) poses a significant threat to immunocompromised patients due to its inherent resistance to various antifungal drugs. This study explored the anticandidal potential of citral, linalool, and carvacrol in combination with nystatin against P. kudriavzevii strains. Using the microdilution method following CLSI guidelines, Minimum Inhibitory Concentrations (MICs) and fungicidal concentrations (MFCs) were determined. Citral exhibited MIC values ranging from 50 to 100 µg/ml, averaging 70.24 ± 16.99 µg/ml, while carvacrol had MIC values of 50 to 100 µg/ml, averaging 86.90 ± 16.99 µg/ml. Linalool demonstrated weaker antifungal activity, with MIC values between 100 and 200 µg/ml, averaging 150 ± 38.73 µg/ml. The study assessed the synergistic effectsof these phenols with nystatin through fractional inhibitory concentration indices (FICIS). In addition, flow cytometry was employed to assess apoptosis induction in P. kudriavzevii cells. Carvacrol displayed a remarkable synergistic effect in combination with nystatin against all 21 isolates tested. Conversely, linalool showed synergy in 17 isolates, while citral exhibited synergy in only 2 isolates. These findings highlight distinct patterns of synergy between the different compounds and nystatin against P. kudriavzevii. Also, Carvacrol emerged as the most potent inducer of apoptosis across all P. kudriavzevii strains, followed by citral and linalool. This suggests that carvacrol not only possesses a stronger antifungal effect but also has a more pronounced ability to trigger programmed cell death in P. kudriavzevii. In conclusion, the study supports the potential of carvacrol, citral and linalool, as anticandidal agents, suggesting their supplementation with nystatin for treating P. kudriavzevii infections.
- 10 September 2024
- Published by Springer Nature in BMC Microbiology
- Vol. 24 (1) , 1-12
Open AccessEvaluation of antifungal and apoptotic effects of linalool, citral, and carvacrol separately and in combination with nystatin against clinical isolates of Pichia kudriavzevii
Pichia kudriavzevii (formerly Candida krusei) poses a significant threat to immunocompromised patients due to its inherent resistance to various antifungal drugs. This study explored the anticandidal potential of citral, linalool, and carvacrol in combination with nystatin against P. kudriavzevii strains. Using the microdilution method following CLSI guidelines, Minimum Inhibitory Concentrations (MICs) and fungicidal concentrations (MFCs) were determined. Citral exhibited MIC values ranging from 50 to 100 µg/ml, averaging 70.24 ± 16.99 µg/ml, while carvacrol had MIC values of 50 to 100 µg/ml, averaging 86.90 ± 16.99 µg/ml. Linalool demonstrated weaker antifungal activity, with MIC values between 100 and 200 µg/ml, averaging 150 ± 38.73 µg/ml. The study assessed the synergistic effectsof these phenols with nystatin through fractional inhibitory concentration indices (FICIS). In addition, flow cytometry was employed to assess apoptosis induction in P. kudriavzevii cells. Carvacrol displayed a remarkable synergistic effect in combination with nystatin against all 21 isolates tested. Conversely, linalool showed synergy in 17 isolates, while citral exhibited synergy in only 2 isolates. These findings highlight distinct patterns of synergy between the different compounds and nystatin against P. kudriavzevii. Also, Carvacrol emerged as the most potent inducer of apoptosis across all P. kudriavzevii strains, followed by citral and linalool. This suggests that carvacrol not only possesses a stronger antifungal effect but also has a more pronounced ability to trigger programmed cell death in P. kudriavzevii. In conclusion, the study supports the potential of carvacrol, citral and linalool, as anticandidal agents, suggesting their supplementation with nystatin for treating P. kudriavzevii infections.
- Open Access
- 1 April 2024
- Published by Negah Scientific Publisher in Iranian Journal of Veterinary Medicine
- Vol. 18 (02) , 223-232
The in Vitro Effect of Berberine Sulfate and Berberine Chloride on the Growth and Aflatoxin Production by Aspergillus flavus and Aspergillus parasiticus
Background: Aflatoxins are harmful mycotoxins that can contaminate animal and human food products. To prevent toxigenic fungi growth and aflatoxin production, researchers have long investigated plant compounds as potential inhibitory agents. Objectives: This study aimed to evaluate the in vitro effect of berberine sulfate and berberine chloride on the growth and aflatoxin production of Aspergillus flavus and Aspergillus parasiticus. Methods: The antifungal activity of berberine salts was determined according to the Clinical and Laboratory Standards Institute (CLSI) document M38-A3. The aflatoxin levels were measured using high-performance liquid chromatography (HPLC) method. Results: The berberine sulfate and berberine chloride showed inhibitory effects against both Aspergillus species, with minimum inhibitory concentration (MIC) ranging from 125 to 500 µg/mL. Berberine sulfate at 2000 μg/mL and berberine chloride at 1000 μg/mL completely inhibited the mycelial growth of A. flavus, while berberine chloride at 1000 μg/mL also completely inhibited the mycelial growth of A. parasiticus. Berberine sulfate at 2000 µg/mL reduced the mycelial growth of A. parasiticus by 96.7%. Conclusion: Berberine salts significantly decreased the total aflatoxin production of Aspergillus species at MIC/2 and MIC/4 concentrations (P˂0.05). The results suggest that berberine salts could be used as potential antifungal and anti-aflatoxigenic agents against toxigenic Aspergillus isolates.
- 1 April 2024
- Published by Negah Scientific Publisher in Iranian Journal of Veterinary Medicine
- Vol. 18 (02) , 223-232
Open AccessThe in Vitro Effect of Berberine Sulfate and Berberine Chloride on the Growth and Aflatoxin Production by Aspergillus flavus and Aspergillus parasiticus
Background: Aflatoxins are harmful mycotoxins that can contaminate animal and human food products. To prevent toxigenic fungi growth and aflatoxin production, researchers have long investigated plant compounds as potential inhibitory agents. Objectives: This study aimed to evaluate the in vitro effect of berberine sulfate and berberine chloride on the growth and aflatoxin production of Aspergillus flavus and Aspergillus parasiticus. Methods: The antifungal activity of berberine salts was determined according to the Clinical and Laboratory Standards Institute (CLSI) document M38-A3. The aflatoxin levels were measured using high-performance liquid chromatography (HPLC) method. Results: The berberine sulfate and berberine chloride showed inhibitory effects against both Aspergillus species, with minimum inhibitory concentration (MIC) ranging from 125 to 500 µg/mL. Berberine sulfate at 2000 μg/mL and berberine chloride at 1000 μg/mL completely inhibited the mycelial growth of A. flavus, while berberine chloride at 1000 μg/mL also completely inhibited the mycelial growth of A. parasiticus. Berberine sulfate at 2000 µg/mL reduced the mycelial growth of A. parasiticus by 96.7%. Conclusion: Berberine salts significantly decreased the total aflatoxin production of Aspergillus species at MIC/2 and MIC/4 concentrations (P˂0.05). The results suggest that berberine salts could be used as potential antifungal and anti-aflatoxigenic agents against toxigenic Aspergillus isolates.
- 17 January 2023
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 370
Influence of menthol on biofilm formation, ergosterol content, and cell surface hydrophobicity ofCandida glabrata
Resistance to synthetic antifungals has become one of the leading public health challenges around the world. Accordingly, novel antifungal products like naturally occurring molecules can be one of the potential ways to reach efficient curative approaches to control candidiasis. This work evaluated the effect of menthol on cell surface hydrophobicity (CSH), biofilm formation, growth and ergosterol content of Candida glabrata (C. glabrata), a yeast with a high resistance against antifungal agents. Disc diffusion method (susceptibility to synthetic antifungals), broth micro-dilution method (Susceptibility to menthol), MTT reduction assay (biofilm formation), HPLC technique (ergosterol content) and adherence to n-hexadecane (CSH) were employed to determine the influence of menthol against C. glabrata isolates. The MIC range of menthol versus C. glabrata was 1250–5000 µg/mL (mean ± SD: 3375 ± 1375 µg/mL). The mean rate of C. glabrata biofilm formation was decreased up to 97.67, 81.15, 71.21, 63.72, 47.53, 26.31 and 0.051% at 625, 1250, 2500, 5000, 10 000, 20 000 and 40 000 µg/mL concentrations, respectively. The percentages of CSH were significantly in groups treated with MIC/2 (17.51 ± 5.52%) and MIC/4 (26 ± 5.87%) concentrations of menthol. Also, the percentage changes in membrane ergosterol were 15.97, 45.34 and 73.40% at 0.125, 0.25 and 0.5 mg/mL concentrations of menthol, respectively, in comparison with untreated control. The results showed the menthol impact versus sessile and planktonic C. glabrata cells, and the interference with ergosterol content, CSH, and biofilm formation, which made it a potent natural antifungal.
- 17 January 2023
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 370
Influence of menthol on biofilm formation, ergosterol content, and cell surface hydrophobicity ofCandida glabrata
Resistance to synthetic antifungals has become one of the leading public health challenges around the world. Accordingly, novel antifungal products like naturally occurring molecules can be one of the potential ways to reach efficient curative approaches to control candidiasis. This work evaluated the effect of menthol on cell surface hydrophobicity (CSH), biofilm formation, growth and ergosterol content of Candida glabrata (C. glabrata), a yeast with a high resistance against antifungal agents. Disc diffusion method (susceptibility to synthetic antifungals), broth micro-dilution method (Susceptibility to menthol), MTT reduction assay (biofilm formation), HPLC technique (ergosterol content) and adherence to n-hexadecane (CSH) were employed to determine the influence of menthol against C. glabrata isolates. The MIC range of menthol versus C. glabrata was 1250–5000 µg/mL (mean ± SD: 3375 ± 1375 µg/mL). The mean rate of C. glabrata biofilm formation was decreased up to 97.67, 81.15, 71.21, 63.72, 47.53, 26.31 and 0.051% at 625, 1250, 2500, 5000, 10 000, 20 000 and 40 000 µg/mL concentrations, respectively. The percentages of CSH were significantly in groups treated with MIC/2 (17.51 ± 5.52%) and MIC/4 (26 ± 5.87%) concentrations of menthol. Also, the percentage changes in membrane ergosterol were 15.97, 45.34 and 73.40% at 0.125, 0.25 and 0.5 mg/mL concentrations of menthol, respectively, in comparison with untreated control. The results showed the menthol impact versus sessile and planktonic C. glabrata cells, and the interference with ergosterol content, CSH, and biofilm formation, which made it a potent natural antifungal.
- Open Access
- 21 August 2022
- Published by Negah Scientific Publisher in Current Medical Mycology
- Vol. 8 (1) , 12-19
Efficacy of Syzygium aromaticum Essential Oil on the Growth and Enzymatic Activity of Pathogenic Candida albicans Strains
Candida albicans (C. albicans) is the most common human pathogen owing to the most virulence factors. It seems that extracellular hydrolytic enzymes play a key role in C. albicans pathogenicity. The present study aimed to assess the susceptibility and enzymatic activity of pathogenic C. albicans isolates exposed to the Syzygium aromaticum (S. aromaticum) essential oil. S. aromaticum oil was characterized using gas chromatography-mass spectrometry (GC–MS). The broth microdilution technique (CLSI, M27-A3) was used to determine the minimum inhibitory concentration (MIC) of test compounds. Furthermore, before and after treatment with S. aromaticum essential oil, the yeasts were analyzed regarding the proteinase (Prz), hemolysin (Hz), and phospholipase (Phz) production/activity. β-caryophyllene (12.76%) was found to be the major constituent in the essential oil after eugenol (84.64%). Only one isolate of C. albicans showed the antifungal resistance to fluconazole. All isolates were susceptible to S. aromaticum essential oil with MIC of 625-1250 μg/ml. S. aromaticum oil represented the best antifungal effect against C. albicans at MIC 1000 μg/ml. The mean±SD enzyme activity of C. albicans not exposed to S. aromaticum essential oil was obtained at 0.55±0.03, 0.73±0.04, and 0.61±0.05 for proteinase, hemolysin, and phospholipase, respectively. The activities of these enzymes were reduced significantly (P<0.05) to 0.33±0.06, 0.40±0.04, and 0.16±0.03 for phospholipase, proteinase, and hemolysin, respectively, after the yeasts were subjected to S. aromaticum essential oil. The present study aimed to determine the ability of S. aromaticum essential oil to prevent the growth of C. albicans and decrease their enzymatic activity. As a natural antifungal agent, S. aromaticum can be utilized in pharmaceutical systems.
- 21 August 2022
- Published by Negah Scientific Publisher in Current Medical Mycology
- Vol. 8 (1) , 12-19
Open AccessEfficacy of Syzygium aromaticum Essential Oil on the Growth and Enzymatic Activity of Pathogenic Candida albicans Strains
Candida albicans (C. albicans) is the most common human pathogen owing to the most virulence factors. It seems that extracellular hydrolytic enzymes play a key role in C. albicans pathogenicity. The present study aimed to assess the susceptibility and enzymatic activity of pathogenic C. albicans isolates exposed to the Syzygium aromaticum (S. aromaticum) essential oil. S. aromaticum oil was characterized using gas chromatography-mass spectrometry (GC–MS). The broth microdilution technique (CLSI, M27-A3) was used to determine the minimum inhibitory concentration (MIC) of test compounds. Furthermore, before and after treatment with S. aromaticum essential oil, the yeasts were analyzed regarding the proteinase (Prz), hemolysin (Hz), and phospholipase (Phz) production/activity. β-caryophyllene (12.76%) was found to be the major constituent in the essential oil after eugenol (84.64%). Only one isolate of C. albicans showed the antifungal resistance to fluconazole. All isolates were susceptible to S. aromaticum essential oil with MIC of 625-1250 μg/ml. S. aromaticum oil represented the best antifungal effect against C. albicans at MIC 1000 μg/ml. The mean±SD enzyme activity of C. albicans not exposed to S. aromaticum essential oil was obtained at 0.55±0.03, 0.73±0.04, and 0.61±0.05 for proteinase, hemolysin, and phospholipase, respectively. The activities of these enzymes were reduced significantly (P<0.05) to 0.33±0.06, 0.40±0.04, and 0.16±0.03 for phospholipase, proteinase, and hemolysin, respectively, after the yeasts were subjected to S. aromaticum essential oil. The present study aimed to determine the ability of S. aromaticum essential oil to prevent the growth of C. albicans and decrease their enzymatic activity. As a natural antifungal agent, S. aromaticum can be utilized in pharmaceutical systems.